158 related articles for article (PubMed ID: 24060925)
21. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
Kulkarni AS; Gaja JB
PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
[TBL] [Abstract][Full Text] [Related]
22. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
[TBL] [Abstract][Full Text] [Related]
23. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.
Javadzadeh Y; Shariati H; Movahhed-Danesh E; Nokhodchi A
Drug Dev Ind Pharm; 2009 Feb; 35(2):243-51. PubMed ID: 18785038
[TBL] [Abstract][Full Text] [Related]
24. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
Rahman Z; Zidan AS; Berendt RT; Khan MA
Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
Fahmy RH; Kassem MA
Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of griseofulvin release from liquisolid compacts.
Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
[TBL] [Abstract][Full Text] [Related]
27. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles.
Elkordy AA; Tan XN; Essa EA
Eur J Pharm Biopharm; 2013 Feb; 83(2):203-23. PubMed ID: 22960707
[TBL] [Abstract][Full Text] [Related]
28. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
Hentzschel CM; Sakmann A; Leopold CS
Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
[TBL] [Abstract][Full Text] [Related]
29. Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies.
Azharshekoufeh L; Shokri J; Barzegar-Jalali M; Javadzadeh Y
Bioimpacts; 2017; 7(1):5-12. PubMed ID: 28546948
[No Abstract] [Full Text] [Related]
30. Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms.
Khames A
Expert Opin Drug Deliv; 2013 Oct; 10(10):1335-43. PubMed ID: 23706099
[TBL] [Abstract][Full Text] [Related]
31. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
[TBL] [Abstract][Full Text] [Related]
33. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.
El-Hammadi M; Awad N
AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967
[TBL] [Abstract][Full Text] [Related]
34. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
35. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.
Vittal GV; Deveswaran R; Bharath S; Basavaraj B; Madhavan V
Int J Pharm Investig; 2012 Jul; 2(3):150-6. PubMed ID: 23373006
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.
Venkateswarlu K; Preethi JK; Chandrasekhar KB
Adv Pharm Bull; 2016 Sep; 6(3):385-390. PubMed ID: 27766222
[No Abstract] [Full Text] [Related]
37. Formulation of fenofibrate liquisolid tablets using central composite design.
Patel T; Patel LD; Suhagia BN; Soni T; Patel T
Curr Drug Deliv; 2014; 11(1):11-23. PubMed ID: 24712439
[TBL] [Abstract][Full Text] [Related]
38. Liquisolid systems to improve the dissolution of furosemide.
Akinlade B; Elkordy AA; Essa EA; Elhagar S
Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
[TBL] [Abstract][Full Text] [Related]
39. Liquisolid systems: Understanding the impact of drug state (solution or dispersion), nonvolatile solvent and coating material on simvastatin apparent aqueous solubility and flowability.
Anzilaggo D; O'Reilly Beringhs A; Pezzini BR; Sonaglio D; Stulzer HK
Colloids Surf B Biointerfaces; 2019 Mar; 175():36-43. PubMed ID: 30517903
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations.
Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M
Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
